nach oben

Erschienen in:

01.01.2010 | Drug and Profile Reports

Ferric carboxymaltose: a guide to its use in iron-deficiency anaemia

Erschienen in: Drugs & Therapy Perspectives | Ausgabe 1/2010

Einloggen, um Zugang zu erhalten

Excerpt

Ferric carboxymaltose, a novel iron complex that consists of a ferric hydroxide core stabilized by a carbohydrate shell, allows for controlled delivery of iron. Administered intravenously, it is effective in the treatment of iron-deficiency anaemia, delivering a replenishment dose of up to 1000 mg of iron (maximum dose 15 mg/kg bodyweight per week). Adapted from Drugs 2009; 69 (6): 739-56.[1] …

Lyseng-Williamson KA, Keating GM. Ferric carboxymaltose: a review of its use in iron-deficiency anaemia. Drugs 2009; 69(6): 739–56PubMedCrossRef

Ferinject: UK summary of product characteristics. Purley: Syner-Med (Pharmaceutical Products) Ltd, 2009 Jul 9

Geisser P. The pharmacology and safety profile of ferric carboxymaltose (Ferinject®): structure/reactivity relationships of iron preparations. Port J Nephrol Hypert 2009; 23(1): 11–6

UK Medicines and Healthcare Products Regulatory Agency. Public assessment report (decentralised procedure): Ferinject 50mg iron/ml solution for injection/infusion (PL 15240/0002; UK/H/0894/001/DC) [online]. Available from URL: http://www.mhra.gov.uk [Accessed 2009 Oct 30]

Kulnigg S, Stoinov S, Simanenkov V, et al. A novel intravenous iron formulation for treatment of anemia in inflammatory bowel disease: the ferric carboxymaltose (Ferinject®) randomized controlled trial. Am J Gastroenterol 2008 May; 103(5): 1182–92PubMedCrossRef

Van Wyck DB, Mangione A, Morrison J, et al. Large-dose intravenous ferric carboxymaltose injection for iron deficiency anemia in heavy uterine bleeding: a randomized, controlled trial. Transfusion. Epub 2009 Jul 22

Breymann C, Gliga F, Bejenariu C, et al. Comparative efficacy and safety of intravenous ferric carboxymaltose in the treatment of postpartum iron deficiency anemia. Int J Gynaecol Obstet 2008 Apr; 101(1): 67–73PubMedCrossRef

Seid MH, Derman RJ, Baker JB, et al. Ferric carboxymaltose injection in the treatment of postpartum iron deficiency anemia: a randomized controlled clinical trial. Am J Obstet Gynecol 2008 Oct; 199(4): 435.e1–7CrossRef

Van Wyck DB, Martens MG, Seid MH, et al. Intravenous ferric carboxymaltose compared with oral iron in the treatment of postpartum anemia: a randomized controlled trial. Obstet Gynecol 2007 Aug; 110(2 Pt 1): 267–78PubMedCrossRef

10.

Qunibi WY, Martinez C, Smith M, et al. Efficacy and safety of IV ferric carboxymaltose (FCM) compared to oral iron in anemic patients with non-dialysis-dependent CKD [abstract no. MO0 17 plus poster]. 45th Congress of the European Renal Association and the European Dialysis and Transplant Association; 2008 May 10–13; Stockholm

11.

Schaefer RM, Khasabov NN, Todorov NG, et al. The efficacy and safety of intravenous ferric carboxymaltose compared to iron sucrose in haemodialysis patients with iron deficiency anaemia [abstract no. MP375 plus poster]. 45th Congress of the European Renal Association and the European Dialysis and Transplant Association; 2008 May 10–13; Stockholm

12.

Qunibi W, Dinh Q, Benjamin J. Safety and tolerability profile of ferric carboxymaltose (FCM): data from the FCM clinical program, [abstract no. MP383 plus poster]. 45th Congress of the European Renal Association and the European Dialysis and Transplant Association; 2008 May 10–13; Stockholm

13.

Seid MH, Mangione A, Valaoras TG, et al. Safety profile of iron carboxymaltose, a new high dose intravenous iron in patients with iron deficiency anemia [abstract no. 3739]. Blood 2006 Nov 2; 108(11 Pt 2): 8b

Titel: Ferric carboxymaltose: a guide to its use in iron-deficiency anaemia
Publikationsdatum: 01.01.2010
Verlag: Springer International Publishing
Erschienen in: Drugs & Therapy Perspectives / Ausgabe 1/2010
Print ISSN: 1172-0360
Elektronische ISSN: 1179-1977
DOI: https://doi.org/10.2165/11203350-000000000-00000

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Ferric carboxymaltose: a guide to its use in iron-deficiency anaemia

Excerpt

Die Highlights vom Kongress des American College of Cardiology 2024

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2010

Worldwide control of trachoma involves a strategy combining surgery, antibacterials, facial cleanliness and environmental improvements

First reports of serious adverse drug reactions in recent weeks

News from the 38th European Symposium on Clinical Pharmacy; 3–6 November 2009; Geneva

Antidepressants are the main options for the long-term pharmacological treatment of generalized anxiety disorder

Glitazones accelerate bone loss and increase the risk of fracture in patients with type 2 diabetes mellitus

Fesoterodine: a guide to its use in overactive bladder syndrome